GlassScriptPhysician profile
Abhinav Singla
NPI 1104230002
$5,101.40
in general payments reported to CMS, 2019-2025
10 companies · $1,783 in 2025
The $1,783 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $129 · 2021: $85.41 · 2022: $39.38 · 2023: $2,811 · 2024: $52.71 · 2025: $1,783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,752 · Consulting Fee: $1,750 · Food and Beverage: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,752.00 |
| Consulting Fee | $1,750.00 |
| Food and Beverage | $144.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $2,767.55 | 2020-2023 | Rexulti |
| Merck Sharp & Dohme LLC | $1,927.27 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $100.66 | 2019 | |
| Sk Life Science, INC. | $85.04 | 2022-2023 | |
| Glaxosmithkline, LLC. | $64.56 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $57.05 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $54.62 | 2024-2025 | Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $17.56 | 2024 | |
| Novo Nordisk INC | $13.70 | 2025 | |
| Impel Pharmaceuticals INC. | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhinav Singla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.